Nevertheless, a link has been recently identified between a subclass of HERVs and the ability to trigger pathologic innate immune signaling in cancer involving STING and IFNγ, with important implications for PD-L1 expression and cancer immunotherapy [63]. The gene discussed is IFNG; the disease is cancer.